Cita APA

Gleason, R. L., Caulk, A. W., Seifu, D., Parker, I., Vidakovic, B., Getenet, H., . . . Amogne, W. (2015). Current Efavirenz (EFV) or Ritonavir-Boosted Lopinavir (LPV/r) Use Correlates with Elevate Markers of Atherosclerosis in HIV-Infected Subjects in Addis Ababa, Ethiopia. PLoS One.

Chicago Style Citation

Gleason, Rudolph L., Alexander W. Caulk, Daniel Seifu, Ivana Parker, Brani Vidakovic, Helena Getenet, Getachew Assefa, i Wondwossen Amogne. "Current Efavirenz (EFV) or Ritonavir-Boosted Lopinavir (LPV/r) Use Correlates With Elevate Markers of Atherosclerosis in HIV-Infected Subjects in Addis Ababa, Ethiopia." PLoS One 2015.

Cita MLA

Gleason, Rudolph L., et al. "Current Efavirenz (EFV) or Ritonavir-Boosted Lopinavir (LPV/r) Use Correlates With Elevate Markers of Atherosclerosis in HIV-Infected Subjects in Addis Ababa, Ethiopia." PLoS One 2015.